Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients

BACKGROUND: We estimated the prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA). The concordance between macromethod and glycopeptide resistance detection (GRD) E tests was determined. In addition, predictors of clinical outcomes in hospitalized pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Young Rae, Kim, Kye-Hyung, Chang, Chulhun L., Yi, Jongyoun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Laboratory Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773264/
https://www.ncbi.nlm.nih.gov/pubmed/26915612
http://dx.doi.org/10.3343/alm.2016.36.3.235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773264/
https://www.ncbi.nlm.nih.gov/pubmed/26915612
http://dx.doi.org/10.3343/alm.2016.36.3.235

Ejemplares similares